NRXP
HEALTHCARENRX Pharmaceuticals Inc
$3.05+0.01 (+0.33%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving NRXP Today?
No stock-specific AI insight has been generated for NRXP yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$1.62$3.84
$3.05
Fundamentals
Market Cap$101M
P/E Ratio—
EPS$-1.34
Dividend Yield—
Dividend / Share—
ROE-6.8%
Profit Margin—
Debt / Equity—
Trading
Volume1.1M
Avg Volume (10D)—
Shares Outstanding33.1M
NRXP News
20 articles- NRx Pharmaceuticals (Nasdaq:NRXP) Announces FDA Clearance to Proceed with Clinical Trial of NRX-101 in Combination with Robotic-enabled Transcranial Magnetic Stimulation in Patients with Depression and SuicidalityYahoo Finance·May 7, 2026
- NRx Pharmaceuticals (Nasdaq:NRXP) Announces Initiation of Commercial Manufacturing for Preservative Free KetamineYahoo Finance·May 5, 2026
- GLOBAL MARKETS SPOTLIGHT: New to The Street Show #748 Delivers High-Impact CEO Interviews and Spotlight TV Commercials Across Bloomberg to 250M+ Households WorldwideYahoo Finance·May 1, 2026
- New to The Street Broadcasts Show #746 Tonight on Bloomberg Television 6:30PM EST Featuring NRx Pharma (NASDAQ:NRXP), Performance Golf, Lost Soldier Oil & Gas, Dr. Lee Gause, and CISO GlobalYahoo Finance·Apr 25, 2026
- NRx Pharmaceuticals Reports Positive FDA Office of Generic Drugs Feedback on Preservative-Free Ketamine ProgramYahoo Finance·Apr 22, 2026
- NRx Pharmaceuticals (Nasdaq:NRXP) Welcomes Presidential Initiative to Accelerate Approval of Psychedelic Medications to Treat Depression, PTSD, and SuicidalityYahoo Finance·Apr 20, 2026
- NRx Pharmaceuticals Advances Robotic-Enabled Transcranial Magnetic Stimulation Combined with Neuroplastic Therapy for Military and First Responder ApplicationsYahoo Finance·Apr 15, 2026
- NRx Pharmaceuticals (Nasdaq:NRXP) Announces Appointment of Glenn Tyson as the Company’s first Chief Commercial OfficerGlobeNewswire Inc.·Apr 13, 2026
- Weekly Roundup on the Cannabis Sector & Psychedelic SectorYahoo Finance·Apr 6, 2026
- NRx Pharmaceuticals (Nasdaq:NRXP) Announces FDA Labeling Alignment for NRx’s Preservative-Free Ketamine ApplicationGlobeNewswire Inc.·Apr 6, 2026
- Hope Therapeutics, an NRx Pharmaceuticals Subsidiary (Nasdaq:NRXP), Announces Strategic Partnership with Emobot to Integrate its AI-Powered “Depression Thermometer” Across its Interventional Psychiatry NetworkYahoo Finance·Mar 30, 2026
- NRx Pharmaceuticals (NASDAQ:NRXP) Is In A Good Position To Deliver On Growth PlansYahoo Finance·Mar 29, 2026
- New to The Street Broadcasts Show #740 on Bloomberg Television at 6:30 PM EST Featuring Medicus (MDCX), Acme Markets- Canton Foundation, Alpha Ton Capital (ATON), and Virtuix Holdings (NASDAQ:VTIX)Yahoo Finance·Mar 28, 2026
- NRx Pharmaceuticals (NRXP) Looks to Score Double With ANDA and NDA Filings For NRX-101Yahoo Finance·Mar 25, 2026
- NRx Pharmaceuticals, Inc. Q4 2025 Earnings Call SummaryMoby·Mar 25, 2026
- NRX Pharmaceuticals Inc (NRXP) Q4 2025 Earnings Call Highlights: Strategic Advances and ...Yahoo Finance·Mar 24, 2026
- NRx Pharmaceuticals Q4 Earnings Call HighlightsMarketbeat·Mar 24, 2026
- NRx Pharmaceuticals (Nasdaq:NRXP) Reports Full-Year 2025 Results and Highlights Key Regulatory and Commercial ProgressYahoo Finance·Mar 24, 2026
- NRx Pharmaceuticals Wraps Virtual Annual Meeting, Eyes Pivotal 2025 Earnings Call AheadMarketbeat·Mar 24, 2026
- NRx Pharmaceuticals, Inc. (NRXP) Surpasses Q4 Earnings EstimatesYahoo Finance·Mar 23, 2026
All 20 articles loaded
Price Data
Open$3.04
Previous Close$3.04
Day High$3.10
Day Low$2.92
52 Week High$3.84
52 Week Low$1.62
52-Week Range
$1.62$3.84
$3.05
Fundamentals
Market Cap$101M
P/E Ratio—
EPS$-1.34
Dividend Yield—
Dividend / Share—
ROE-6.8%
Profit Margin—
Debt / Equity—
Trading
Volume1.1M
Avg Volume (10D)—
Shares Outstanding33.1M
About NRX Pharmaceuticals Inc
NRx Pharmaceuticals, Inc., a clinical-stage small molecule pharmaceutical company, develops new treatments for the treatment of life-threatening central nervous system disorders and lung diseases. The company is headquartered in Wilmington, Delaware.
HEALTHCAREBIOTECHNOLOGY
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICBIOTECHNOLOGY
CIK—
Composite FIGI—
Share Class FIGI—